167 related articles for article (PubMed ID: 34284778)
21. Evaluation of onchocerciasis seroprevalence in Bioko Island (Equatorial Guinea) after years of disease control programmes.
Hernández-González A; Moya L; Perteguer MJ; Herrador Z; Nguema R; Nguema J; Aparicio P; Benito A; Gárate T
Parasit Vectors; 2016 Sep; 9(1):509. PubMed ID: 27645887
[TBL] [Abstract][Full Text] [Related]
22. An epidemiological study of malaria in Bioko and Annobón islands (Equatorial Guinea).
Roche J; de Diego JA; Penin P; Santos M; del Rey J
Ann Trop Med Parasitol; 1991 Oct; 85(5):477-87. PubMed ID: 1809240
[TBL] [Abstract][Full Text] [Related]
23. Plasmodium diversity in non-malaria individuals from the Bioko Island in Equatorial Guinea (West Central-Africa).
Guerra-Neira A; Rubio JM; Royo JR; Ortega JC; Auñón AS; Diaz PB; Llanes AB
Int J Health Geogr; 2006 Jun; 5():27. PubMed ID: 16784527
[TBL] [Abstract][Full Text] [Related]
24. Impact of different strategies to control Plasmodium infection and anaemia on the island of Bioko (Equatorial Guinea).
Pardo G; Descalzo MA; Molina L; Custodio E; Lwanga M; Mangue C; Obono J; Nchama A; Roche J; Benito A; Cano J
Malar J; 2006 Feb; 5():10. PubMed ID: 16460558
[TBL] [Abstract][Full Text] [Related]
25. Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines.
Richie TL; Billingsley PF; Sim BK; James ER; Chakravarty S; Epstein JE; Lyke KE; Mordmüller B; Alonso P; Duffy PE; Doumbo OK; Sauerwein RW; Tanner M; Abdulla S; Kremsner PG; Seder RA; Hoffman SL
Vaccine; 2015 Dec; 33(52):7452-61. PubMed ID: 26469720
[TBL] [Abstract][Full Text] [Related]
26. PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial.
Coulibaly D; Kone AK; Traore K; Niangaly A; Kouriba B; Arama C; Zeguime A; Dolo A; Lyke KE; Plowe CV; Abebe Y; Potter GE; Kennedy JK; Galbiati SM; Nomicos E; Deye GA; Richie TL; James ER; Kc N; Sim BKL; Hoffman SL; Doumbo OK; Thera MA; Laurens MB;
EClinicalMedicine; 2022 Oct; 52():101579. PubMed ID: 35928033
[TBL] [Abstract][Full Text] [Related]
27. Infection importation: a key challenge to malaria elimination on Bioko Island, Equatorial Guinea.
Bradley J; Monti F; Rehman AM; Schwabe C; Vargas D; Garcia G; Hergott D; Riloha M; Kleinschmidt I
Malar J; 2015 Feb; 14():46. PubMed ID: 25651929
[TBL] [Abstract][Full Text] [Related]
28. Molecular mutation profile of Pfcrt and Pfmdr1 in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea.
Li J; Chen J; Xie D; Eyi UM; Matesa RA; Obono MMO; Ehapo CS; Yang L; Yang H; Lin M; Wu W; Wu K; Li S; Chen Z
Infect Genet Evol; 2015 Dec; 36():552-556. PubMed ID: 26325683
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity and Protective Efficacy of Radiation-Attenuated and Chemo-Attenuated PfSPZ Vaccines in Equatoguinean Adults.
Jongo SA; Urbano V; Church LWP; Olotu A; Manock SR; Schindler T; Mtoro A; Kc N; Hamad A; Nyakarungu E; Mpina M; Deal A; Bijeri JR; Ondo Mangue ME; Ntutumu Pasialo BE; Nguema GN; Owono SN; Rivas MR; Chemba M; Kassim KR; James ER; Stabler TC; Abebe Y; Saverino E; Sax J; Hosch S; Tumbo AM; Gondwe L; Segura JL; Falla CC; Phiri WP; Hergott DEB; García GA; Schwabe C; Maas CD; Murshedkar T; Billingsley PF; Tanner M; Ayekaba MO; Sim BKL; Daubenberger C; Richie TL; Abdulla S; Hoffman SL
Am J Trop Med Hyg; 2021 Jan; 104(1):283-293. PubMed ID: 33205741
[No Abstract] [Full Text] [Related]
30. Malaria outbreak in Riaba district, Bioko Island: lessons learned.
Guerra CA; Fuseini G; Donfack OT; Smith JM; Ondo Mifumu TA; Akadiri G; Eyang DEM; Eburi CO; Motobe Vaz L; Micha VM; Okenve LA; Janes CR; Andeme RM; Rivas MR; Phiri WP; Slotman MA; Smith DL; García GA
Malar J; 2020 Aug; 19(1):277. PubMed ID: 32746919
[TBL] [Abstract][Full Text] [Related]
31. High prevalence of Pfdhfr-Pfdhps quadruple mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea.
Jiang T; Chen J; Fu H; Wu K; Yao Y; Eyi JUM; Matesa RA; Obono MMO; Du W; Tan H; Lin M; Li J
Malar J; 2019 Mar; 18(1):101. PubMed ID: 30914041
[TBL] [Abstract][Full Text] [Related]
32. Factors influencing the effectiveness of malaria control in Bioko Island, equatorial Guinea.
Kleinschmidt I; Torrez M; Schwabe C; Benavente L; Seocharan I; Jituboh D; Nseng G; Sharp B
Am J Trop Med Hyg; 2007 Jun; 76(6):1027-32. PubMed ID: 17556606
[TBL] [Abstract][Full Text] [Related]
33. Limited artemisinin resistance-associated polymorphisms in Plasmodium falciparum K13-propeller and PfATPase6 gene isolated from Bioko Island, Equatorial Guinea.
Li J; Chen J; Xie D; Eyi UM; Matesa RA; Ondo Obono MM; Ehapo CS; Yang L; Yang H; Lin M
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):54-59. PubMed ID: 27054064
[TBL] [Abstract][Full Text] [Related]
34. Natural selection and genetic diversity of domain I of Plasmodium falciparum apical membrane antigen-1 on Bioko Island.
Wang YN; Lin M; Liang XY; Chen JT; Xie DD; Wang YL; Ehapo CS; Eyi UM; Huang HY; Wu JL; Xu DY; Chen ZM; Cao YL; Chen HB
Malar J; 2019 Sep; 18(1):317. PubMed ID: 31533747
[TBL] [Abstract][Full Text] [Related]
35. Characterising co-infections with Plasmodium spp., Mansonella perstans or Loa loa in asymptomatic children, adults and elderly people living on Bioko Island using nucleic acids extracted from malaria rapid diagnostic tests.
Yoboue CA; Hosch S; Donfack OT; Guirou EA; Nlavo BM; Ayekaba MO; Guerra C; Phiri WP; Garcia GA; Schindler T; Daubenberger CA
PLoS Negl Trop Dis; 2022 Jan; 16(1):e0009798. PubMed ID: 35100277
[TBL] [Abstract][Full Text] [Related]
36. Transmission of malaria and genotypic variability of Plasmodium falciparum on the island of Annobon (Equatorial Guinea).
Cano J; Berzosa P; de Lucio A; Descalzo MA; Bobuakasi L; Nzambo S; Ondo M; Buatiche JN; Nseng G; Benito A
Malar J; 2007 Oct; 6():141. PubMed ID: 17961248
[TBL] [Abstract][Full Text] [Related]
37. Increased risks of malaria due to limited residual life of insecticide and outdoor biting versus protection by combined use of nets and indoor residual spraying on Bioko Island, Equatorial Guinea.
Bradley J; Matias A; Schwabe C; Vargas D; Monti F; Nseng G; Kleinschmidt I
Malar J; 2012 Jul; 11():242. PubMed ID: 22835049
[TBL] [Abstract][Full Text] [Related]
38. The impact of Loa loa microfilaraemia on research subject retention during a whole sporozoite malaria vaccine trial in Equatorial Guinea.
Manock SR; Nsue VU; Olotu A; Mpina M; Nyakarungu E; Raso J; Mtoro A; Ondo Mangue ME; Ntutumu Pasialo BE; Nguema R; Riyahi P; Schindler T; Daubenberger C; Church LWP; Billingsley PF; Richie TL; Abdulla S; Hoffman SL
Trans R Soc Trop Med Hyg; 2022 Aug; 116(8):745-749. PubMed ID: 35394038
[TBL] [Abstract][Full Text] [Related]
39. Declining malaria transmission in rural Amazon: changing epidemiology and challenges to achieve elimination.
Vitor-Silva S; Siqueira AM; de Souza Sampaio V; Guinovart C; Reyes-Lecca RC; de Melo GC; Monteiro WM; Del Portillo HA; Alonso P; Bassat Q; Lacerda MV
Malar J; 2016 May; 15(1):266. PubMed ID: 27165432
[TBL] [Abstract][Full Text] [Related]
40. Genetic polymorphism of Plasmodium falciparum circumsporozoite protein on Bioko Island, Equatorial Guinea and global comparative analysis.
Huang HY; Liang XY; Lin LY; Chen JT; Ehapo CS; Eyi UM; Li J; Jiang TT; Zheng YZ; Zha GC; Xie DD; He JQ; Chen WZ; Liu XZ; Mo HT; Chen XY; Lin M
Malar J; 2020 Jul; 19(1):245. PubMed ID: 32660484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
